- Pierre-Yves Bochud, research fellowa,
- Thierry Calandra (Thierry.Calandra@chuv.hospvd.ch), associate professorb
- a Institute for Systems Biology, 1441 North 34th Street, Seattle, WA 98103-8904, USA
- b Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland
- Correspondence to: T Calandra
Severe sepsis and septic shock are important causes of death in intensive care units. Although our understanding of the pathogenesis of inflammation and sepsis has improved, until recently this has not translated into clinical benefit. Several new treatment approaches have given encouraging results. Evidence suggests that the way forward is to develop pathogen specific regimens rather than assume that one treatment fits all.
Summary points
Bacterial cell walls, endotoxins, and exotoxins are powerful activators of innate and acquired immune responses
Molecules expressed by pathogens interact with Toll-like receptors on immune cells, activating the immune response
Cytokines are important in the pathogenesis of sepsis
Susceptibility to sepsis may be due to inherited or acquired mutations of innate immune genes
Severe sepsis and septic shock are clinical manifestations of a dysregulated immune response to invasive pathogens
Adjunctive therapy with low dose steroids, activated protein C or early supportive care can reduce mortality from severe sepsis and septic shock
Pathogen recognition receptors (such as Toll-like receptors) and mediators of sepsis (such as macrophage migration inhibitory factor) might be novel targets for treatment
Sources and methods
We selected articles for this review by searching Medline using the keywords sepsis, therapy, and Toll-like receptors. We concentrated on publications on the pathogenesis of sepsis and treatment of septic shock. As the number of references that could be cited was limited, we have often referenced review articles rather than original publications.
Epidemiology and importance of severe sepsis and septic shock
Severe sepsis and septic shock are life threatening complications of infections and the most common cause of death in intensive care units. However, a lack of widely accepted definitions of these complications has made it difficult to obtain accurate estimates of their frequency. A study published by the Centers for Disease Control in the United States indicated that the incidence of septicaemia had increased from 73.6 per 100 000 patients in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.